
Bio Essence
(OTC) BIOE
Bio Essence Financials at a Glance
Market Cap
$12.82M
Revenue (TTM)
$2.38M
Net Income (TTM)
$1.31M
EPS (TTM)
$0.03
P/E Ratio
8.15
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.27
Volume
55
Open
$0.27
Price
$0.27
Volume
55
Open
$0.27
Previous Close
$0.27
Daily Range
$0.27 - $0.27
52-Week Range
$0.05 - $0.52
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.27
Volume
55
Open
$0.27
Previous Close
$0.27
Daily Range
$0.27 - $0.27
52-Week Range
$0.05 - $0.52
BIOE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bio Essence
Industry
Pharmaceuticals
Sector
Health CareEmployees
4
CEO
Yin Yan, MBA
Website
www.bioessencecorp.comHeadquarters
Irvine, CA 92618, US
BIOE Financials
Key Financial Metrics (TTM)
Gross Margin
73%
Operating Margin
56%
Net Income Margin
55%
Return on Equity
0%
Return on Capital
-96%
Return on Assets
2%
Earnings Yield
12.27%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$12.82M
Shares Outstanding
46.81M
Volume
55
Avg. Volume
4.18K
Financials (TTM)
Gross Profit
$1.43M
Operating Income
$900.01K
EBITDA
$900.01K
Operating Cash Flow
$1.57M
Capital Expenditure
-$3.00
Free Cash Flow
$1.57M
Cash & ST Invst.
$0.00
Total Debt
$1.56M
Bio Essence Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$500.54K
+2155.8%
Gross Profit
$319.35K
+1451.2%
Gross Margin
63.80%
N/A
Market Cap
$12.82M
N/A
Market Cap/Employee
$6.41M
N/A
Employees
2
N/A
Net Income
$205.37K
+199.8%
EBITDA
$215.80K
+205.2%
Quarterly Fundamentals
Net Cash
-$1.53M
+44.2%
Accounts Receivable
$380.49K
+85.2%
Inventory
$0.00
N/A
Long Term Debt
$55.68K
-81.6%
Short Term Debt
$1.51M
-38.1%
Return on Assets
1.66%
N/A
Return on Invested Capital
-96.29%
N/A
Free Cash Flow
-$411.97K
-1480.3%
Operating Cash Flow
-$411.97K
-1480.3%